Philips North America has been the subject of 355 FDA enforcement/approval records tracked by Argus HQ, compared to 4 for Reliance Life Sciences Private Limited.
Philips North America: 0 warning letters, 355 recalls, 0 approval records, 0 Form 483s.
Reliance Life Sciences Private Limited: 0 warning letters, 4 recalls, 0 approval records, 0 Form 483s.
Side by side
Philips North America — Warning letters0
Reliance Life Sciences Private Limited — Warning letters0
Philips North America — Recalls355
Reliance Life Sciences Private Limited — Recalls4
Philips North America — Approval records0
Reliance Life Sciences Private Limited — Approval records0
Philips North America — Form 483s0
Reliance Life Sciences Private Limited — Form 483s0
Timeline
Cite this comparison
Pre-formatted for a story, footnote, or reference list:
"Philips North America vs Reliance Life Sciences Private Limited: FDA Enforcement Comparison." Argus HQ, accessed July 24, 2026. https://argushq.ai/compare/philips-north-america-vs-reliance-life-sciences-private-limited
Source: FDA.gov (aggregated across Warning Letters, Recalls, Approvals, Form 483s) ↗